US FDA adds label warning to J&J’s and Legend Biotech’s cancer therapy
NegativeFinancial Markets

The US FDA has issued a label warning for the cancer therapy developed by Johnson & Johnson and Legend Biotech, highlighting potential risks associated with the treatment. This development is significant as it raises concerns about patient safety and could impact the therapy's usage in clinical settings. The warning may lead to increased scrutiny from healthcare providers and patients alike, emphasizing the importance of thorough communication regarding treatment options.
— Curated by the World Pulse Now AI Editorial System